Geron Corp (NASDAQ: GERN) on Monday, soared 3.42% from the previous trading day, before settling in for the closing price of $1.17. Within the past 52 weeks, GERN’s price has moved between $1.09 and $4.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.60%. The company achieved an average annual earnings per share of 52.25%. With a float of $603.39 million, this company’s outstanding shares have now reached $636.92 million.
Let’s determine the extent of company efficiency that accounts for 229 employees. In terms of profitability, gross margin is 97.85%, operating margin of -115.49%, and the pretax margin is -119.54%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Geron Corp is 5.26%, while institutional ownership is 76.69%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 52.25% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Geron Corp (GERN) is currently performing well based on its current performance indicators. A quick ratio of 6.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 11.15 million, which is a drop from its year-to-date volume of 12.7 million. As of the previous 9 days, the stock’s Stochastic %D was 30.95%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 15.00%, which indicates a significant decrease from 42.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0782 in the past 14 days, which was lower than the 0.1039 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4037, while its 200-day Moving Average is $2.3876.
